Research is key to future treatment
The BRC is a partnership between The Royal Marsden and The Institute of Cancer Research, London. It supports innovative translational research, taking leading-edge cancer research from the laboratory and rapidly translating it into a clinical setting.
What does the future hold for breast cancer?
Register now for our patient & public engagement event on Tuesday 1 October 2019.
Latest news
News: AI reveals breast cancer types that respond differently to treatment
Scientists have used artificial intelligence to recognise patterns in breast cancer – and uncovered five new types of the disease each matched to different personalised treatments
Find out more
News: Personalised ‘liquid biopsy’ could detect return of breast cancer
A new study at five UK hospitals has found that a personalised blood test for women with early breast cancer could detect the return of the disease nearly eleven months earlier than hospital scans.
Find out more
News: Immunotherapy option for bowel cancer
A major new study reveals that bowel cancer patients who have become resistant to a widely used targeted treatment could benefit from immunotherapy.
Find out more